This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Regular Home-use Dual Light Photodynamic Therapy in the Prevention of Osteolysis After Dental Implant Surgery

Sponsored by Koite Health Oy

About this trial

Last updated 2 years ago

Study ID

LumOsteo

Status

Not yet recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 85 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 2 years ago

What is this trial about?

The aim of the study is to determine whether regular use of the antibacterial, photodynamic, CE-marked Lumoral device reduces the risk of osteolysis after dental implant surgery. The study also aims to find out whether Lumoral treatment can replace the use of chlorhexidine. Subjects will be randomized into two groups (20 + 20 subjects) and all will be given individual guidance on maintaining good oral hygiene. The participants in the study group will also be given Lumoral appliances with instructions for use at home. The Lumoral device has been shown in previous studies to be safe to use and effective in eliminating harmful oral bacteria.

What are the participation requirements?

Yes

Inclusion Criteria

- Age of ≥ 18 years

- Generally healthy,

- At least one new implant inserted

- New implant inserted

- Agreement to participate in the study with a written consent form signed

No

Exclusion Criteria

- Uncontrolled diabetes mellitus (DM)

- Active smoking

- Any significant systemic disease

- Immediate implantation after tooth extraction

- Use of antibiotics within 4 weeks week prior study

- Presence of any physical limitation or restriction that might restrict Lumoral use

- Pregnancy or lactation

- History of six months use of antimicrobials, bisphosphonates, or corticosteroids.

Locations

Location

Status